Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 9;11(3):e95.
doi: 10.1192/bjo.2025.28.

Individual-level brain phenotypes in first-episode mania: normative modelling of brain morphometry and brainAGE

Affiliations

Individual-level brain phenotypes in first-episode mania: normative modelling of brain morphometry and brainAGE

Kevin Yu et al. BJPsych Open. .

Abstract

Background: Brain morphological alterations in bipolar disorder are well documented, particularly in chronic cases. This study focuses on first-episode mania (FEM) to quantify neuroanatomical changes at early stages of the disorder.

Aims: To assess deviations from normative brain morphometry and age-related brain changes in patients with FEM.

Method: Pretrained models, based on large, independent healthy samples, were applied to structural brain images from FEM patients (n = 83) and healthy individuals (n = 61). Normative deviation z-scores were computed for regional brain morphometry, along with global and voxel-level brain-age-gap estimates (G-brainAGE and L-brainAGE, respectively). The proportions of infranormal (z < -1.96) and supranormal (z > 1.96) deviations were measured for both groups. Ridge regression and support vector machine models were used to evaluate whether z-scores predicted symptom severity, IQ or diagnosis. Case-control differences in L-brainAGE and correlations between G-brainAGE and clinical features were analysed.

Results: Both FEM and healthy individuals showed similar proportions of infra- and supranormal deviations in regional measures. Morphometric data, whether observed or normative, did not significantly predict clinical outcomes or diagnosis. Mean G-brainAGE in FEM was -1.04 (s.d. 3.26) years and negatively correlated with age of onset, while L-brainAGE did not differ significantly between groups.

Conclusions: Regional morphometry and local brain-ageing metrics in FEM patients aligned with normative ranges, suggesting minimal abnormalities in early bipolar disorder. However, subtle delays in global brain ageing may reflect variation based on the age of onset, highlighting a potential area for further exploration.

Keywords: Bipolar disorder; brainAGE; first-episode mania; structural MRI.

PubMed Disclaimer

Conflict of interest statement

L.N.Y. reports consultant/speaker fees from Alkermes, Allergan (currently Abbvie), Sumitomo Pharma, Intracellular Therapies, LivaNova, Merck, Sanofi and Sunovion, and grants from Allergan (now AbbVie), CIHR and Sumitomo, outside the submitted work, over the last 3 years. All other authors report no conflicts of interest.

Figures

Fig. 1
Fig. 1
Distributions of observed regional morphometric measures in patients with first-episode mania (FEM) and healthy individuals.
Fig. 2
Fig. 2
Distributions of regional z-scores in patients with first-episode mania (FEM) and healthy individuals.
Fig. 3
Fig. 3
Distribution of the total number of regions with infra- or supranormal regional normative z-scores in patients with first-episode mania (FEM) and healthy individuals. Bar plots show the distribution of the total number of regions per individual, with infranormal (top) and supranormal (bottom) z-score in patients with FEM and in healthy individuals.
Fig. 4
Fig. 4
Predictive performance of regional z-scores and observed regional brain morphometric measures for psychopathology and general cognition in patients with first-episode mania. Separate ridge regression analyses were conducted for each outcome measure. Lower MAE and RMSE values (top) and higher correlation values (bottom) indicate better performance. MADRS, Montgomery–Åsberg Depression Rating Scale; MAE, mean absolute error; NAART, North American Adult Reading Test; RMSE, root mean square error; YMRS, Young Mania Rating Scale.
Fig. 5
Fig. 5
Receiver operator curves of models using either regional z-scores or observed regional brain morphometric measures for diagnostic classification. A linear support vector machine was applied to distinguish between patients and healthy individuals using either regional brain z-scores (indicated by the blue line, with area under the curve, AUC, 0.51) or observed morphometric measures (red line, with AUC 0.47).

Similar articles

  • Normative Modeling of Brain Morphometry in Clinical High Risk for Psychosis.
    ENIGMA Clinical High Risk for Psychosis Working Group; Haas SS, Ge R, Agartz I, Amminger GP, Andreassen OA, Bachman P, Baeza I, Choi S, Colibazzi T, Cropley VL, de la Fuente-Sandoval C, Ebdrup BH, Fortea A, Fusar-Poli P, Glenthøj BY, Glenthøj LB, Haut KM, Hayes RA, Heekeren K, Hooker CI, Hwang WJ, Jahanshad N, Kaess M, Kasai K, Katagiri N, Kim M, Kindler J, Koike S, Kristensen TD, Kwon JS, Lawrie SM, Lebedeva I, Lee J, Lemmers-Jansen ILJ, Lin A, Ma X, Mathalon DH, McGuire P, Michel C, Mizrahi R, Mizuno M, Møller P, Mora-Durán R, Nelson B, Nemoto T, Nordentoft M, Nordholm D, Omelchenko MA, Pantelis C, Pariente JC, Raghava JM, Reyes-Madrigal F, Røssberg JI, Rössler W, Salisbury DF, Sasabayashi D, Schall U, Smigielski L, Sugranyes G, Suzuki M, Takahashi T, Tamnes CK, Theodoridou A, Thomopoulos SI, Thompson PM, Tomyshev AS, Uhlhaas PJ, Værnes TG, van Amelsvoort TAMJ, van Erp TGM, Waltz JA, Wenneberg C, Westlye LT, Wood SJ, Zhou JH, Hernaus D, Jalbrzikowski M, Kahn RS, Corcoran CM, Frangou S. ENIGMA Clinical High Risk for Psychosis Working Group, et al. JAMA Psychiatry. 2024 Jan 1;81(1):77-88. doi: 10.1001/jamapsychiatry.2023.3850. JAMA Psychiatry. 2024. PMID: 37819650 Free PMC article.
  • Normative modeling of brain morphometry in Clinical High-Risk for Psychosis.
    Haas SS, Ge R, Agartz I, Amminger GP, Andreassen OA, Bachman P, Baeza I, Choi S, Colibazzi T, Cropley VL, de la Fuente-Sandoval C, Ebdrup BH, Fortea A, Fusar-Poli P, Glenthøj BY, Glenthøj LB, Haut KM, Hayes RA, Heekeren K, Hooker CI, Hwang WJ, Jahanshad N, Kaess M, Kasai K, Katagiri N, Kim M, Kindler J, Koike S, Kristensen TD, Kwon JS, Lawrie SM, Lee J, Lemmers-Jansen IL, Lin A, Ma X, Mathalon DH, McGuire P, Michel C, Mizrahi R, Mizuno M, Møller P, Mora-Durán R, Nelson B, Nemoto T, Nordentoft M, Nordholm D, Omelchenko MA, Pantelis C, Pariente JC, Raghava JM, Reyes-Madrigal F, Røssberg JI, Rössler W, Salisbury DF, Sasabayashi D, Schall U, Smigielski L, Sugranyes G, Suzuki M, Takahashi T, Tamnes CK, Theodoridou A, Thomopoulos SI, Thompson PM, Tomyshev AS, Uhlhaas PJ, Værnes TG, van Amelsvoort TA, van Erp TG, Waltz JA, Wenneberg C, Westlye LT, Wood SJ, Zhou JH, Hernaus D, Jalbrzikowski M, Kahn RS, Corcoran CM, Frangou S; ENIGMA Clinical High Risk for Psychosis Working Group. Haas SS, et al. bioRxiv [Preprint]. 2023 Jan 18:2023.01.17.523348. doi: 10.1101/2023.01.17.523348. bioRxiv. 2023. Update in: JAMA Psychiatry. 2024 Jan 1;81(1):77-88. doi: 10.1001/jamapsychiatry.2023.3850. PMID: 36711551 Free PMC article. Updated. Preprint.
  • Contrasting Case-Control and Normative Reference Approaches to Capture Clinically Relevant Structural Brain Abnormalities in Patients With First-Episode Psychosis Who Are Antipsychotic Naive.
    Remiszewski N, Bryant JE, Rutherford SE, Marquand AF, Nelson E, Askar I, Lahti AC, Kraguljac NV. Remiszewski N, et al. JAMA Psychiatry. 2022 Nov 1;79(11):1133-1138. doi: 10.1001/jamapsychiatry.2022.3010. JAMA Psychiatry. 2022. PMID: 36169987 Free PMC article. Clinical Trial.
  • Psychological therapies for post-traumatic stress disorder and comorbid substance use disorder.
    Roberts NP, Roberts PA, Jones N, Bisson JI. Roberts NP, et al. Cochrane Database Syst Rev. 2016 Apr 4;4(4):CD010204. doi: 10.1002/14651858.CD010204.pub2. Cochrane Database Syst Rev. 2016. PMID: 27040448 Free PMC article.
  • Early intervention for psychosis.
    Marshall M, Rathbone J. Marshall M, et al. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD004718. doi: 10.1002/14651858.CD004718.pub2. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2011 Jun 15;(6):CD004718. doi: 10.1002/14651858.CD004718.pub3. PMID: 17054213 Updated.

References

    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th edn). APA, 2013.
    1. GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry 2022; 9: 137–50. - PMC - PubMed
    1. Hibar DP, Westlye LT, van Erp TG, Rasmussen J, Leonardo CD, Faskowitz J, et al. Subcortical volumetric abnormalities in bipolar disorder. Mol Psychiatry 2016; 21: 1710–6. - PMC - PubMed
    1. Hibar DP, Westlye LT, Doan NT, Jahanshad N, Cheung JW, Ching CRK, et al. Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group. Mol Psychiatry 2018; 23: 932–42. - PMC - PubMed
    1. Chen G, Wang J, Gong J, Qi Z, Fu S, Tang G, et al. Functional and structural brain differences in bipolar disorder: a multimodal meta-analysis of neuroimaging studies. Psychol Med 2022; 52: 2861–73. - PubMed

LinkOut - more resources